Blog | NanoMosaic LLC

NanoMosaic Announces Its Second Commercial Sale of the World's First Proteomics/Multi-Omics System,

BOSTON, Feb. 15, 2022 /PRNewswire/ -- NanoMosaic Inc., the pioneer and leader in nanoneedle (MosaicNeedle™) technology detection for...

NanoMosaic Announces its "Proteomics/Multi-Omics Early Access Program" and its First System Sale to

BOSTON, Feb. 2, 2022 /PRNewswire/ -- NanoMosaic Inc., the pioneer and leader in nanoneedle (MosaicNeedle™) technology detection for...

NanoMosaic Signs 31K Square Foot Lease and Establishes "Multi-Omics World Headquarters" in Waltham,

BOSTON, Jan. 24, 2022 /PRNewswire/ -- NanoMosaic, the pioneer and leader in nanoneedle (MosaicNeedle™) technology detection for...

NanoMosaic Closes a $40.75MM Over-Subscribed Series A Round

Plans for Near-Term Commercialization of its Proteomics and Multi-Omics System https://www.prnewswire.com/news-releases/nanomosaic-closes...

NanoMosaic Demonstrates Robust Aptamer Performance for Protein Quantitation on the Company's Tessie™

https://www.prnewswire.com/news-releases/nanomosaic-demonstrates-robust-aptamer-performance-for-protein-quantitation-on-the-companys-tess...

NanoMosaic Unveils Full Proteome Wide Association Study (PWAS) Marker Set Development at 2021 AACR

BOSTON, April 13, 2021 /PRNewswire/ -- NanoMosaic, the pioneer and leader in nanoneedle (MosaicNeedle™) detection for proteomics and...

NanoMosaic Installs Wide Dynamic Range Proteomic Beta System at The NYSCF

NEW YORK, April 6, 2021 /PRNewswire/ -- NanoMosaic, the pioneer and leader in nanoneedle (MosaicNeedle™) detection for proteomics and...

NanoMosaic Tessie To Run Clinical Samples At Massachusetts General Hospital Beta Placement

https://www.prnewswire.com/news-releases/nanomosaic-announces-beta-placement-of-its-tessie-system-at-massachusetts-general-hospital-to-ru...

NanoMosaic Ships First Beta System To A Prestigious Institution

MosaicNeedles™, which are novel physical structures, will greatly increase the number of potential protein targets in pharmaceutical...

Protein Detection Pioneer, NanoMosaic, Prepares to Ship Its Powerful New Beta Platform in the Battle

NanoMosaic prepares for its first beta platform launch. "Tessie": A powerful platform equipped to unravel the mysteries of disease by...

NanoMosaic In The News:

NanoMosaic Takes Aim at Proteomics Research Market With Label-Free Sensing Platforms (Reporter, Adam Bonislawski with genomeweb)

2020 AACR: NanoMosaic Unveils Ultra-sensitive Quantitative Platform

WOBURN, Mass., July 1, 2020 NanoMosaic L.L.C. – Woburn, MA – the leading company in protein and nucleic acid detection leveraging the...

NanoMosaic announces collaboration with Massachusetts General Hospital to Develop Test for COVID-19

Leading clinicians at MGH will assess the effect of FDA approved treatments and methodologies on the effect of COVID-19 and utilize...

NanoMosaic Announces Exclusive License to Nanoneedle Technology from Harvard

BOSTON, April 2, 2020 /PRNewswire/ -- NanoMosaic L.L.C. announced today it is commercializing technology for high-throughput,...